CytRx Corporation (NASDAQ: CYTR) announced that its investigational cancer drug INNO-206 caused a dramatic destruction of implanted tumors in an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE